Dacogen decitabine: Phase II data

Interim data from a Phase II trial in 29 evaluable treatment-naïve elderly patients showed a 62% overall response rate with 4 CRs, 5 PRs and 9 AEs. Stable disease was seen in 3 patients and 7 had prog...